Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data
© van Baal et al; licensee BioMed Central Ltd. 2011
Received: 4 March 2011
Accepted: 1 September 2011
Published: 1 September 2011
The high prevalence of chronic diseases in Western countries implies that the presence of multiple chronic diseases within one person is common. Especially at older ages, when the likelihood of having a chronic disease increases, the co-occurrence of distinct diseases will be encountered more frequently. The aim of this study was to estimate the age-specific prevalence of multimorbidity in the general population. In particular, we investigate to what extent specific pairs of diseases cluster within people and how this deviates from what is to be expected under the assumption of the independent occurrence of diseases (i.e., sheer coincidence).
We used data from a Dutch health survey to estimate the prevalence of pairs of chronic diseases specified by age. Diseases we focused on were diabetes, myocardial infarction, stroke, and cancer. Multinomial P-splines were fitted to the data to model the relation between age and disease status (single versus two diseases). To assess to what extent co-occurrence cannot be explained by independent occurrence, we estimated observed/expected co-occurrence ratios using predictions of the fitted regression models.
Prevalence increased with age for all disease pairs. For all disease pairs, prevalence at most ages was much higher than is to be expected on the basis of coincidence. Observed/expected ratios of disease combinations decreased with age.
Common chronic diseases co-occur in one individual more frequently than is due to chance. In monitoring the occurrence of diseases among the population at large, such multimorbidity is insufficiently taken into account.
Keywordsmultimorbidity comorbidity diabetes cancer cardiovascular disease stroke P-splines
The prevalence of chronic diseases has increased strongly the last few decades in most Western countries [1, 2]. Besides aging of the population, this is also partly due to increased survival in people with many chronic conditions [3, 4]. Given the high prevalence of chronic diseases, it is not surprising that the presence of multiple chronic diseases within one person has also become more common . This phenomenon is known as multimorbidity, or as comorbidity if one disease is considered as the primary, or index, condition . Even if we assume that diseases are distributed randomly and occur independently of each other, we expect a great share of multimorbidity at older ages [7, 8]. For instance, if 20% of those 65 years or older suffer from diabetes mellitus (DM) and if the prevalence of osteoarthritis is 20% in this group, 4% will suffer from both diabetes and osteoarthritis by sheer coincidence. Clustering of diseases in individuals is to be expected for several reasons [6, 9]. First, as mentioned, on the basis of coincidence, and second, because some diseases are known to be causally related. For instance, diabetes is a risk factor for acute myocardial infarction (AMI) and stroke (cerebrovascular accident [CVA]) and, therefore, these diseases will be more common among diabetics. Thirdly, clustering of diseases can result from the presence of common underlying known or unknown risk factors, as many risk factors (e.g., smoking and BMI) are related to multiple chronic diseases. And finally, diseases tend to cluster within individuals due to differences in individual susceptibility to disease. In elderly people, this is often referred to as frailty .
Multimorbidity is often used as an explanatory variable in research to adjust for "case mix," or as a determinant of prognosis of the main disease of interest . However, the view that multimorbidity is an object of study in itself is gaining support [9, 12]. Since people with multimorbidity have an increased mortality risk, higher health care utilization, and greater quality of life losses than people with a single disease , any description of the distribution of diseases in the population at large is incomplete without estimates of how often combinations of chronic diseases occur. Moreover, as the co-occurrence of common chronic diseases is more frequent than is to be expected on the basis of chance, monitoring of the prevalence of multimorbidity seems a logical thing to do in an aging society. In this manner, it might be possible to better identify groups at increased risk, to identify new risk factors that specifically apply to comorbidity, and thus to devise appropriate public health interventions. Furthermore, given the current attention on medical guidelines and disease management programs, it is crucial to take multimorbidity into account [9, 14, 15].
The associations between some specific pairs of diseases have been investigated in more detail, in particular causally-related diseases. Thus, in numerous studies the occurrence of diseases, such as coronary heart disease and stroke in diabetics, has been investigated [16–18]. Much less is known about the clustering of other disease combinations, such as heart disease and cancer, in the general population. Another issue that has rarely been addressed explicitly is the role of age . Even though it is to be expected that the prevalence of multimorbidity increases with age, it would be interesting to gain more insight into the nature of this relation, and how this, in turn, relates to the age-dependence of the prevalence of the individual diseases. In this article we compare the joint occurrence of pairs of four of the most prevalent chronic diseases (diabetes, AMI, cancer, and stroke), and we focus especially on the role of age. We estimate to what extent specific pairs of diseases cluster within people and how this deviates from what is to be expected under the assumption of independence.
We used data from the Permanent Survey of Living Conditions (POLS: Permanent Onderzoek LeefSituatie) covering the years 2001 to 2007. POLS is an ongoing yearly cross-sectional survey, started in 1981 and coordinated by Statistics Netherlands . The POLS survey data, which require no ethics approval, is publicly available from http://www.dans.knaw.nl. POLS monitors developments in lifestyle, health, medical consumption, preventive behavior, and well-being in the Netherlands. Before 1997, the surveys used to be sampled with households as the underlying unit. Since 1997, surveys have been sampled on the basis of person records from a centralized municipal registry. The interviewer visits the participants at home, asks for informed consent and leaves a written (drop-off) questionnaire. Yearly net participation currently ranges around 10,000 individuals, with response percentages of around 60%. In the POLS surveys in the years 2001 to 2007, the following questions on disease status were included:
1. Diabetes: Do you have diabetes?
2. Stroke: Did you ever experience a stroke, cerebral hemorrhage, or cerebral infarction?
3. AMI: Did you ever experience a myocardial infarction?
4. Cancer: Did you ever have a cancer?
Characteristics of the POLS survey, 2001-2007
A key feature of cubic B-splines is that any linear combination of the basis functions will result in a smooth function with a second-order derivative that is continuous at the joining points. Cubic B-splines share the advantage of dummy variables (local basis) and polynomials (smoothness) without their disadvantages. For dummy variables, a disadvantage is that the age gradient would not be smooth, while with polynomials, values at high ages can strongly influence the fit at lower ages. The drawback of B-splines and other forms of local regression is that it is difficult to determine the number of knots and spacing of the basis functions. As a solution to this problem, P-splines were proposed. The general idea behind P-splines is to use a relatively large number of knots and to put a penalty on the difference between the coefficients of adjacent cubic B-spline functions. The optimal amount of smoothing in P-splines is then determined by adjusting the weight of the penalty using cross-validation or an information criterion. In our analyses, the optimal smoothing parameters were found by minimizing the Aikaike Information Criterion (in Additional file 1 results are presented when the Bayesian information is used instead). All analyses were done in R http://www.r-project.org
Confidence intervals around these outcome measures were calculated using Monte Carlo simulations. Regression coefficients of the regression models were repeatedly drawn from a multivariate normal distribution (sample size was set at 10,000). For each draw of the regression coefficients, predictions were made and observed/expected differences and ratios were calculated. After all draws were performed, confidence intervals were obtained by taking the 2.5th and 97.5th percentiles of the outcome measures.
From Figure 2 it can be seen that, in general, prevalence for all diseases and disease combinations increases with age, but that the rate of increase is lower (or even negative) at higher ages. If we look, for instance, at the upper left panel of Figure 2, at age 80 years about 12% of people have diabetes without ever having experienced a stroke, about 7% of people have experienced a stroke but do not have diabetes, and about 2% of the 80 year olds have diabetes and a history of stroke.
Discussion and conclusions
In this study, we estimated the age-specific joint prevalence of all pairs of four of the most prevalent chronic diseases in the Dutch population. Co-occurrence of all disease pairs studied was seen to increase with age. The joint prevalence was highest for diabetes and AMI, while cancer and stroke co-occurred the least frequently. For all pairs not including cancer, co-occurrence was more frequent for all age groups than expected when the individual diseases occur independently. Thus, observed minus expected proportions increased with age, while the corresponding observed/expected ratios became smaller. This implies that although at lower ages co-occurrence is less prevalent, at lower ages chronic diseases tend to cluster more within individuals. Diabetes co-occurred frequently with stroke and AMI, which is in line with what is known about the increased risk for these diseases in diabetics. On a relative scale, as measured by the observed/expected ratio, stroke and AMI co-occurred most frequently. This is not surprising, as both events are related in their etiology and share multiple underlying risk factors such as high blood pressure, cholesterol, smoking, and obesity. Cancer, however, seemed to display a somewhat different behavior: within an age range of approximately 60 to 75 years, it co-occurred less frequently than expected with the other three diseases. This pattern was somewhat unexpected and not easy to interpret. On the face of it, this seems to imply that diabetes and cardiovascular diseases "protect" against cancer and/or vice versa. However, to the best of our knowledge, there is no known patho-physiological mechanism that could explain such a relation. Alternatively, it could be a "survivor" effect: those prone to develop both diseases die of cardiovascular disease before reaching the age at which cancer would become symptomatic. Yet another explanation might be that people adapt their lifestyles after being diagnosed with cancer. It needs to be stressed that the uncertainty in these estimates is large, and that the findings regarding cancer can be due to chance. Although interesting, at this point we cannot attach much significance to this observation.
A limitation of our study was that the institutionalized population was not included in the survey. As the prevalence of chronic diseases is probably higher among those institutionalized , this exclusion is likely to have led to some degree of underestimation of the prevalence of co-occurrence of chronic diseases. Furthermore, the response rate in this survey was not much more than 60%, which is a potential source of bias. Also, the self-reported nature of the data may have induced some bias in different ways. First, people might not accurately report their disease status. However, previous studies showed that self-reports of chronic conditions were fairly accurate, suggesting that this form of bias probably remained limited [23, 24]. Second, if nonresponse was related to disease status, bias would result. To investigate whether this was the case, we compared our estimates to other national representative estimates of diagnosed disease prevalence [1, 25, 26]. Although estimates of cancer and diabetes prevalence were very similar, our estimates for AMI and stroke appear to be high. This could possibly be explained by a less-stringent case definition. Third, even if people report accurately and there is no selective nonresponse, undiagnosed cases will be missed. In case of diabetes, it has been argued that for every diagnosed diabetes case, there may be around 0.5 to one undiagnosed case. Thus, the true prevalences include, depending on the type of disease and other factors, variable proportions of people with no current morbidity or disability. Although there has been an upward trend in the ratio of undiagnosed/diagnosed cases of diabetes in the Netherlands , there are no recent observational studies in the Netherlands that have presented estimates of disease co-occurrence among diabetics. If there still is substantial underdiagnosis, we hypothesize that having a diabetes diagnosis is more likely in people with comorbidity. This would imply that our estimates of observed/expected ratios could be too high. Other limitations of our analyses are that cancer was treated as a single entity, whereas it is heterogeneous condition, and that no distinction was made between diabetes Types 1 and 2.
A few remarks are necessary regarding the method we used in modeling the joint presence of two diseases in the same individuals. Most importantly, we aimed at expressing prevalence as a function of age. With two diseases there are four possibilities. Hence, the outcome variable has a multinomial distribution, which we related to age using P-splines. The advantage of P-splines compared to polynomial regression is that model fit at the lower ages is not influenced by that at higher ages, and vice versa. That is, P-splines can be seen as a form of "local" regression. Furthermore, with P-splines it is not necessary to choose a more or less arbitrary number of knots, which is often seen as a drawback of other types of splines, such as B-splines. The choice of the smoothing parameter(s) for P-splines is data driven. In our analyses, we used the Akaike information criterion (AIC) criterion, which was also used by Eilers and Marx . In Additional file 1, results are shown when the Bayesian information criterion (BIC) is used to find the optimal smoothing parameter. In general, the results are similar, but a bit smoother and less wiggly when the BIC criterion is used compared to the AIC criterion. For the absolute co-occurrence prevalence, the estimates do not differ much between the AIC and BIC. However, for the observed/expected ratios, there is a clear influence at lower ages, in which the prevalences are generally low. The observed/expected ratios at those ages are much higher if the BIC is used. Finally, it should be noted that in order to increase power, we combined both sexes and pooled all years. This means that the estimates are time- and gender-averaged. Stratifying the analyses by sex and analyzing time trends would therefore be a next step.
Although the "clustering" of chronic diseases is not a surprise, quantitative data on multimorbidity are scarce. Especially at older ages, the co-occurrence of chronic conditions starts to become so common that individuals with more than one disease can no longer be considered the exception. This not only has consequences for disease management programs, but also guidelines should more explicitly address the issue of comorbidity than has hitherto been done. The fact that the care for this category of patients poses specific difficulties requiring a distinctive approach is still insufficiently recognized. A better appreciation of the epidemiology of multimorbidity is a first step to bring the magnitude of the problem into focus. A noteworthy point of our study is that we have presented estimates combining cancer with noncancerous diseases. Although cancer incidence and prevalence are usually well-monitored by cancer registrations, these are not often linked to noncancerous diseases.
In conclusion, in this study we quantified age-specific co-occurrence patterns. It is clear that with increasing age, multimorbidity becomes common. More importantly, the prevalence of multimorbidity most of the time is much greater than would be the case if diseases occur independently from each other. Thus, the practice in epidemiological and public health research to monitor individual diseases tells only part of the story. With an aging population, it is important to quantify the problem of multimorbidity. Those involved in the management of care, the drafters of guidelines, and the doctors treating patients with more than one disease should develop strategies to improve the care for this category of patients that is becoming more numerous as the population ages.
This work was funded by the Dutch Ministry of Health, Welfare and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Baan CA, van Baal PH, Jacobs-van der Bruggen MA, et al.: [Diabetes mellitus in the Netherlands: estimate of the current disease burden and prognosis for 2025]. Ned Tijdschr Geneeskd 2009, 153: 1052-1058.PubMed
- Redfield MM: Heart failure--an epidemic of uncertain proportions. N Engl J Med 2002, 347: 1442-1444. 10.1056/NEJMe020115View ArticlePubMed
- Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K: The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008, 51: 2187-2196. 10.1007/s00125-008-1156-zView ArticlePubMed
- Billett J, Majeed A, Gatzoulis M, Cowie M: Trends in hospital admissions, in-hospital case fatality and population mortality from congenital heart disease in England, 1994 to 2004. Heart 2008, 94: 342-8. 10.1136/hrt.2006.113787View ArticlePubMed
- Uijen AA, van de Lisdonk EH: Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract 2008,14(Suppl 1):28-32.View ArticlePubMed
- Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA: Causes and consequences of comorbidity: a review. J Clin Epidemiol 2001, 54: 661-674. 10.1016/S0895-4356(00)00363-2View ArticlePubMed
- van Baal PH, Hoeymans N, Hoogenveen RT, de Wit GA, Westert GP: Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr 2006, 4: 1. 10.1186/1478-7954-4-1PubMed CentralView ArticlePubMed
- Mathers CD, Iburg KM, Begg S: Adjusting for dependent comorbidity in the calculation of healthy life expectancy. Popul Health Metr 2006, 4: 4. 10.1186/1478-7954-4-4PubMed CentralView ArticlePubMed
- van Weel C, Schellevis FG: Comorbidity and guidelines: conflicting interests. Lancet 2006, 367: 550-551. 10.1016/S0140-6736(06)68198-1View ArticlePubMed
- Fries JF: Frailty, heart disease, and stroke: the Compression of Morbidity paradigm. Am J Prev Med 2005, 29: 164-168. 10.1016/j.amepre.2005.07.004View ArticlePubMed
- Tessier A, Finch L, Daskalopoulou SS, Mayo NE: Validation of the Charlson Comorbidity Index for predicting functional outcome of stroke. Arch Phys Med Rehabil 2008, 89: 1276-1283. 10.1016/j.apmr.2007.11.049View ArticlePubMed
- Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L: Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005, 3: 223-228. 10.1370/afm.272PubMed CentralView ArticlePubMed
- Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA: Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res 2006, 6: 84. 10.1186/1472-6963-6-84PubMed CentralView ArticlePubMed
- Westert GP, Satariano WA, Schellevis FG, van den Bos GA: Patterns of comorbidity and the use of health services in the Dutch population. Eur J Public Health 2001, 11: 365-372. 10.1093/eurpub/11.4.365View ArticlePubMed
- Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005, 294: 716-724. 10.1001/jama.294.6.716View ArticlePubMed
- Wirehn AB, Ostgren CJ, Carstensen JM: Age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease: a population-based register study. Diabetes Res Clin Pract 2008, 79: 497-502. 10.1016/j.diabres.2007.10.009View ArticlePubMed
- Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA: Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 2003, 46: 899-909. 10.1007/s00125-003-1137-1View ArticlePubMed
- Alexander CM, Landsman PB, Teutsch SM: Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 2000, 86: 897-902. 10.1016/S0002-9149(00)01118-8View ArticlePubMed
- Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW: The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 2008, 67: 124-132. 10.1016/j.critrevonc.2008.01.013PubMed CentralView ArticlePubMed
- Statistics Netherlands: STATLINE.[http://www.statline.nl]
- Eilers PH, Marx BD: Flexible smoothing with B-splines and penalties (with comments and rejoinder). Stat Sci 1996, 11: 89-121. 10.1214/ss/1038425655View Article
- Nihtila EK, Martikainen PT, Koskinen SV, Reunanen AR, Noro AM, Hakkinen UT: Chronic conditions and the risk of long-term institutionalization among older people. Eur J Public Health 2008, 18: 77-84. 10.1093/eurpub/ckm025View ArticlePubMed
- Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ: Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996, 49: 1407-1417. 10.1016/S0895-4356(96)00274-0View ArticlePubMed
- Metzger MH, Goldberg M, Chastang JF, Leclerc A, Zins M: Factors associated with self-reporting of chronic health problems in the French GAZEL cohort. J Clin Epidemiol 2002, 55: 48-59. 10.1016/S0895-4356(01)00409-7View ArticlePubMed
- Kiemeney LA, Lemmers FA, Verhoeven RH, et al.: The risk of cancer in the Netherlands. Ned Tijdschr Geneeskd 2008, 152: 2233-2241.PubMed
- van Baal PH, Engelfriet PM, Hoogenveen RT, Poos MJ, van den Dungen C, Boshuizen HC: Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty. BMC Public Health 2011, 11: 163. 10.1186/1471-2458-11-163PubMed CentralView ArticlePubMed
- van 't Riet E: Hyperglycemia: causes and consequences. In PhD Thesis. Amsterdam: Vrije Universiteit; 2011.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.